Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Cilley

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Haematologica|January 26, 2006
Radioimmunotherapy and autologous stem cell transplantation for the treatment of B-cell lymphomasJeffrey Cilley, Jane N Winter
Current Oncology Reports|April 19, 2006
Adjuvant therapy for colon cancerJeffrey Cilley, Mary F Mulcahy
Haematologica|June 15, 2004
Definition of myeloid engraftment after allogeneic hematopoietic stem cell transplantationChristopher Rihn, Jeffrey Cilley, Payal Naik, et al.
Journal of Medical Case Reports|July 17, 2008
Multiple myeloma presenting with high-output heart failure and improving with anti-angiogenesis therapy: two case reports and a review of the literatureJason Robin, Bara Fintel, Olga Pikovskaya, et al.
Leukemia & Lymphoma|August 22, 2012
Bortezomib may be safely combined with Y-90-ibritumomab tiuxetan in patients with relapsed/refractory follicular non-Hodgkin lymphoma: a phase I trial of combined induction therapy and bortezomib consolidationRupali Roy, Andrew M Evens, David Patton, et al.
British Journal of Haematology|April 27, 2007
G-CSF is not necessary to maintain over 99% dose-intensity with ABVD in the treatment of Hodgkin lymphoma: low toxicity and excellent outcomes in a 10-year analysisAndrew M Evens, Jeffrey Cilley, Taylor Ortiz, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Haematologica|January 26, 2006
Radioimmunotherapy and autologous stem cell transplantation for the treatment of B-cell lymphomasJeffrey Cilley, Jane N Winter
Current Oncology Reports|April 19, 2006
Adjuvant therapy for colon cancerJeffrey Cilley, Mary F Mulcahy
Haematologica|June 15, 2004
Definition of myeloid engraftment after allogeneic hematopoietic stem cell transplantationChristopher Rihn, Jeffrey Cilley, Payal Naik, et al.
Journal of Medical Case Reports|July 17, 2008
Multiple myeloma presenting with high-output heart failure and improving with anti-angiogenesis therapy: two case reports and a review of the literatureJason Robin, Bara Fintel, Olga Pikovskaya, et al.
Leukemia & Lymphoma|August 22, 2012
Bortezomib may be safely combined with Y-90-ibritumomab tiuxetan in patients with relapsed/refractory follicular non-Hodgkin lymphoma: a phase I trial of combined induction therapy and bortezomib consolidationRupali Roy, Andrew M Evens, David Patton, et al.
British Journal of Haematology|April 27, 2007
G-CSF is not necessary to maintain over 99% dose-intensity with ABVD in the treatment of Hodgkin lymphoma: low toxicity and excellent outcomes in a 10-year analysisAndrew M Evens, Jeffrey Cilley, Taylor Ortiz, et al.
Pageof 1